DE602005015203D1 - Neue piperidinsubstituierte diaminothiazole - Google Patents

Neue piperidinsubstituierte diaminothiazole

Info

Publication number
DE602005015203D1
DE602005015203D1 DE602005015203T DE602005015203T DE602005015203D1 DE 602005015203 D1 DE602005015203 D1 DE 602005015203D1 DE 602005015203 T DE602005015203 T DE 602005015203T DE 602005015203 T DE602005015203 T DE 602005015203T DE 602005015203 D1 DE602005015203 D1 DE 602005015203D1
Authority
DE
Germany
Prior art keywords
diaminothiazole
substituted
treatment
control
new piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015203T
Other languages
English (en)
Inventor
Qingjie Ding
Nan Jiang
Kyungjin Kim
Allen John Lovey
Warren Williams Mccomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602005015203D1 publication Critical patent/DE602005015203D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
DE602005015203T 2004-04-20 2005-04-08 Neue piperidinsubstituierte diaminothiazole Active DE602005015203D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56371204P 2004-04-20 2004-04-20
PCT/EP2005/003734 WO2005103034A1 (en) 2004-04-20 2005-04-08 Novel piperidine substituted diaminothiazoles

Publications (1)

Publication Number Publication Date
DE602005015203D1 true DE602005015203D1 (de) 2009-08-13

Family

ID=34964131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015203T Active DE602005015203D1 (de) 2004-04-20 2005-04-08 Neue piperidinsubstituierte diaminothiazole

Country Status (14)

Country Link
US (1) US7211576B2 (de)
EP (1) EP1740576B1 (de)
JP (1) JP2007533674A (de)
KR (1) KR100832280B1 (de)
CN (1) CN1942464A (de)
AT (1) ATE435224T1 (de)
AU (1) AU2005235679A1 (de)
BR (1) BRPI0510001A (de)
CA (1) CA2562377A1 (de)
DE (1) DE602005015203D1 (de)
ES (1) ES2327248T3 (de)
MX (1) MXPA06011996A (de)
RU (1) RU2382784C2 (de)
WO (1) WO2005103034A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423053B2 (en) * 2004-07-15 2008-09-09 Hoffmann-La Roche Inc. 4-Aminothiazole derivatives
US7705009B2 (en) * 2005-11-22 2010-04-27 Hoffman-La Roche Inc. 4-aminopyrimidine-5-thione derivatives
US10787410B2 (en) * 2013-12-16 2020-09-29 The Johns Hopkins University Treating and preventing diseases by modulating cell mechanics
EP3324962A4 (de) 2015-07-23 2018-12-19 Temple University Of The Commonwealth System Of Higher Education Neuartige aminothiazolverbindungen und verfahren zur verwendung davon
EP3571196B1 (de) 2017-01-19 2023-01-04 Temple University Of The Commonwealth System Of Higher Education Neuartige verbrückte bicycloalkyl-substituierte aminothizole und verfahren zu deren verwendung
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733920A (en) 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
JP2001509805A (ja) 1997-02-05 2001-07-24 ワーナー−ランバート・コンパニー 細胞増殖阻害剤としてのピリド〔2,3−d〕ピリミジンおよび4−アミノピリミジン
ATE286053T1 (de) 1997-08-20 2005-01-15 Warner Lambert Co Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
YU22400A (sh) * 1997-10-27 2003-08-29 Agouron Pharmaceuticals Inc. Supstituisana 4-amino-tiazol-2-i jedinjenja kao cdks inhibitori
US6040321A (en) 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
AP1258A (en) 1998-02-26 2004-03-15 Aventis Pharma Inc 6,9-Disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines.
US6479487B1 (en) 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
DE69933680T2 (de) 1998-08-29 2007-08-23 Astrazeneca Ab Pyrimidine verbindungen
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
UA71971C2 (en) 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
AU2001230026A1 (en) 2000-02-04 2001-08-14 Novo-Nordisk A/S 2,4-diaminothiazole derivatives
CN1429222A (zh) 2000-02-17 2003-07-09 安姆根有限公司 激酶抑制剂
WO2001079198A1 (en) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles for inhibiting protein kinase
CA2411928A1 (en) 2000-08-09 2002-02-14 Agouron Pharmaceuticals, Inc. Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclindependent kinases
US6756374B2 (en) * 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
US6818663B2 (en) * 2002-05-17 2004-11-16 Hoffmann-La Roches Diaminothiazoles
WO2004014904A1 (en) 2002-08-09 2004-02-19 Pfizer Inc. Antiproliferative 2-(heteroaryl)-aminothiazole compounds, pharmaceutical compositions and methods for their use
US7157455B2 (en) * 2003-02-10 2007-01-02 Hoffmann-La Roche Inc. 4-Aminopyrimidine-5-one derivatives

Also Published As

Publication number Publication date
WO2005103034A1 (en) 2005-11-03
ES2327248T3 (es) 2009-10-27
RU2382784C2 (ru) 2010-02-27
ATE435224T1 (de) 2009-07-15
US20050239843A1 (en) 2005-10-27
MXPA06011996A (es) 2007-04-24
WO2005103034A8 (en) 2006-11-02
EP1740576A1 (de) 2007-01-10
RU2006140862A (ru) 2008-05-27
CA2562377A1 (en) 2005-11-03
CN1942464A (zh) 2007-04-04
US7211576B2 (en) 2007-05-01
AU2005235679A1 (en) 2005-11-03
KR20060135905A (ko) 2006-12-29
KR100832280B1 (ko) 2008-05-26
EP1740576B1 (de) 2009-07-01
JP2007533674A (ja) 2007-11-22
BRPI0510001A (pt) 2007-09-18

Similar Documents

Publication Publication Date Title
BRPI0511975A (pt) pirazolopirimidinas
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
WO2006044826A3 (en) Thiophens and their use as anti-tumor agents
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
TW200628469A (en) Disubstituted pyrazolobenzodiazepines
ATE502025T1 (de) Arylcarboxamide und ihre verwendung als antitumormittel
NO20064894L (no) Beta-karboliner anvendbare for behandling av inflammatoriske sykdommer
ATE435224T1 (de) Neue piperidinsubstituierte diaminothiazole
TW200612929A (en) Novel 2,6-diaminopyridine-3-one derivatives
BRPI0415355A (pt) triarilimidazóis
ATE491696T1 (de) Neue 2,4-diaminothiazol-5-onderivate
BRPI0411126A (pt) derivados de 1,3,4-triaza-fenaleno e 1,3,4,6-tetraazafenaleno
ATE411313T1 (de) Neue makrocyclen zur behandlung von krebserkrankungen
UY27131A1 (es) Diaminotiazoles
GEP20125516B (en) Therapeutic uses of inhibitors of rtp801

Legal Events

Date Code Title Description
8364 No opposition during term of opposition